An interventional study of TEAM and ETAU in Stroke, sponsored by Case Western Reserve University. Completed at 3 sites in Uganda. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-07.
Sponsored by Case Western Reserve University · Not applicable, Interventional, and Treatment
The proposed 2-phase project will first refine the TargetEd MAnageMent (TEAM) intervention to ensure acceptability across a broad range of Ugandans at risk for stroke and then test the effects of TEAM in reducing stroke risk in a 3-site, prospective, 6-month randomized controlled trial (RCT).
In Phase 1 of the project, stakeholder's advisory board (SAB) will be convened across 3 Ugandan sites. The SAB will be composed of up to 15 relevant stakeholders including 3 stroke survivors, 3 individuals with multiple stroke risk factors as defined above, 3 family members, 3 clinicians and 3 administrators who practice in the proposed study enrollment sites. The purpose of the SAB is to refine the TEAM intervention content to meet the needs of patients and professional healthcare stakeholders and suggest how TEAM might best be incorporated into clinical workflow, as well as give guidance and feedback on recruitment methods and advertisements.
Phase 2 of the project will be conducted across 3 Ugandan sites that will enroll a representative sample of Ugandans at risk for stroke (Kiruddu, Nsambya and Mbarara Hospitals and their associated outpatient clinics). In the RCT portion of the study, 246 participants will be randomized at baseline on a 1:1 basis to receive either TEAM (N= 123) or enhanced treatment as usual (ETAU) (N=123) and will be followed for a total of 6 months. Since stroke is a moderately long-term health outcome (years to decades) that typically occurs in the presence of one or more stroke risk factors, the project will focus on testing whether TEAM can modify well-established short-term biomarkers that predict stroke risk, specifically BP control, serum cholesterol and blood glucose control. Secondary outcomes of interest include additional stroke risk biomarkers, (HDL, LDL, triglycerides) diet, exercise, use of alcohol and tobacco, stroke knowledge/attitudes, stress, and treatment adherence with risk-reducing medications. We will also explore associations of age, gender, urban vs. rural residential status and stroke history (prior vs. no previous stroke) on TEAM outcomes. To help inform future scale-up should RCT findings be positive, we will assess barriers and facilitators to TEAM implementation using both qualitative and quantitative methods.
7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.
This study's enrollment of 276 is above the median of 50 across 5,369 interventional studies indexed under Stroke.
Browse Stroke studies →Case Western Reserve University is the lead sponsor of 158 studies on the registry; 29 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 6 (67%) have results posted.
Counted across the registry records on this site, refreshed daily.
At risk for stroke defined by the following:
Exclusion Criteria:
This arm will receive the experimental intervention, TargEted MAnageMent Intervention (TEAM)
Behavioral: TEAM
This arm will receive the control intervention, Enhanced Treatment as Usual (ETAU).
Behavioral: ETAU
TEAM is informed by principles of social cognitive theory TEAM uses nurses and peer educator dyads (PEDs) composed of patients and their care partners to co-deliver an intervention intended to help reduce future stroke risk. Team begins with one 60-minute 1:1 orientation session, in which the nurse and PED meet with the patient and his/her care partner. This is followed by 6 hour-long group sessions with 6-8 patients and their care partners held approximately weekly. The first orientation session will be done approximately 1 week post baseline, followed by group sessions were done at 2, 4, 6, 8, 10 and 12 weeks post-baseline.
ETAU will consist of an orientation visit with a nurse who will provide patient-education materials on stroke risk adapted from the American Heart Association materials and cover common risk factors such as hypertension, obesity, high salt/high fat diet and diabetes. Patients will also receive basic written information in their language of preference and tailored to the reading level of most patients at the clinic. Patients will be offered the opportunity to bring a family member with them to this visit who may also ask questions and who can assist them with understanding written materials for those with limited literacy. The nurse in ETAU will then follow-up with participants with a series of 9 brief phone calls spaced out over the course of 6 months (approximately every 2 weeks during months 1 and 2, then approximately monthly thereafter). Content will reinforce materials provided in the orientation visit and the nurse will be available to answer questions that may arise.
Change From Baseline Systolic Blood Pressure (BP) at 6 Months
Systolic blood pressure indicates how much pressure your blood is exerting against your artery walls when the heart beats. Higher reading implies more pressure
Time frame: Baseline and 6 months
| Milestone | TargEted MAnageMent Intervention (TEAM) | Enhanced Treatment as Usual (ETAU) | Phase 1 Stakeholders | Phase 2: TargEted MAnageMent Intervention (TEAM) - Peer Educators | "Phase 2: TargEted MAnageMent Intervention (TEAM) - Peer Educator Care Partners |
|---|---|---|---|---|---|
| Started | 122 | 125 | 15 | 7 | 7 |
| Completed | 113 | 112 | 15 | 7 | 7 |
| Not completed | 9 | 13 | 0 | 0 | 0 |
Systolic blood pressure indicates how much pressure your blood is exerting against your artery walls when the heart beats. Higher reading implies more pressure
| millimeters of mercury (mmHg) | TargEted MAnageMent Intervention (TEAM) | Enhanced Treatment as Usual (ETAU) |
|---|---|---|
| Baseline | 145.7 ± 21.5 | 141.9 ± 18.4 |
| 6-months | 137.4 ± 18.1 | 141.1 ± 21.9 |
Collected over 6 months. Non-serious events are listed at a 5% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| TargEted MAnageMent Intervention (TEAM) | 2/122 (1.6%) | 1/122 (0.8%) | 0/122 (0%) |
| Enhanced Treatment as Usual (ETAU) | 1/125 (0.8%) | 0/125 (0%) | 0/125 (0%) |
| Phase 1 Stakeholders | 0/15 (0%) | 0/15 (0%) | 0/15 (0%) |
| Phase 2: TargEted MAnageMent Intervention (TEAM) - Peer Educators | 0/7 (0%) | 0/7 (0%) | 0/7 (0%) |
| "Phase 2: TargEted MAnageMent Intervention (TEAM) - Peer Educator Care Partners | 0/7 (0%) | 0/7 (0%) | 0/7 (0%) |
| Event | TargEted MAnageMent Intervention (TEAM) | Enhanced Treatment as Usual (ETAU) | Phase 1 Stakeholders | Phase 2: TargEted MAnageMent Intervention (TEAM) - Peer Educators | "Phase 2: TargEted MAnageMent Intervention (TEAM) - Peer Educator Care Partners |
|---|---|---|---|---|---|
| SepsisGeneral disorders | 1/122 | 0/125 | — | — | — |
Employment status, residency status and family stroke history were not collected on Phase 1 Stakeholders, Phase 2: TargEted MAnageMent Intervention (TEAM) - Peer Educators or Phase 2: TargEted MAnageMent Intervention (TEAM) - Care Partners. We also did not collect marital status or education status on Phase 2: TargEted MAnageMent Intervention (TEAM) - Care Partners.
| Age, Continuous(years) | TargEted MAnageMent Intervention (TEAM) | Enhanced Treatment as Usual (ETAU) | Phase 1 Stakeholders | Phase 2: TargEted MAnageMent Intervention (TEAM) - Peer Educators | Phase 2: TargEted MAnageMent Intervention (TEAM) - Care Partners | Total |
|---|---|---|---|---|---|---|
| Mean | 55.2 ± 11.6 | 55.7 ± 12.5 | 50.6 ± 13.41 | 51.6 ± 12 | 39.4 ± 14.8 | 55.4 ± 12.0 |
| Sex: Female, Male(Participants) | TargEted MAnageMent Intervention (TEAM) | Enhanced Treatment as Usual (ETAU) | Phase 1 Stakeholders | Phase 2: TargEted MAnageMent Intervention (TEAM) - Peer Educators | Phase 2: TargEted MAnageMent Intervention (TEAM) - Care Partners | Total |
|---|---|---|---|---|---|---|
| Female | 84 | 84 | 9 | 5 | 1 | 183 |
| Male | 38 | 41 | 6 | 2 | 4 | 91 |
| Race (NIH/OMB)(Participants) | TargEted MAnageMent Intervention (TEAM) | Enhanced Treatment as Usual (ETAU) | Phase 1 Stakeholders | Phase 2: TargEted MAnageMent Intervention (TEAM) - Peer Educators | Phase 2: TargEted MAnageMent Intervention (TEAM) - Care Partners | Total |
|---|---|---|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 | 0 | 0 | 0 |
| Asian | 0 | 0 | 0 | 0 | 0 | 0 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 | 0 | 0 | 0 |
| Black or African American | 122 | 125 | 15 | 7 | 7 | 276 |
| White | 0 | 0 | 0 | 0 | 0 | 0 |
| More than one race | 0 | 0 | 0 | 0 | 0 | 0 |
| Unknown or Not Reported | 0 | 0 | 0 | 0 | 0 | 0 |
| Region of Enrollment(Participants) | TargEted MAnageMent Intervention (TEAM) | Enhanced Treatment as Usual (ETAU) | Phase 1 Stakeholders | Phase 2: TargEted MAnageMent Intervention (TEAM) - Peer Educators | Phase 2: TargEted MAnageMent Intervention (TEAM) - Care Partners | Total |
|---|---|---|---|---|---|---|
| Uganda | 122 | 125 | 15 | 7 | 7 | 276 |
| Educational Level(Participants) | TargEted MAnageMent Intervention (TEAM) | Enhanced Treatment as Usual (ETAU) | Phase 1 Stakeholders | Phase 2: TargEted MAnageMent Intervention (TEAM) - Peer Educators | Phase 2: TargEted MAnageMent Intervention (TEAM) - Care Partners | Total |
|---|---|---|---|---|---|---|
| None | 10 | 8 | 0 | 0 | — | 18 |
| Primary | 51 | 67 | 1 | 1 | — | 120 |
| Secondary | 51 | 36 | 7 | 1 | — | 95 |
| Tertiary | 10 | 14 | 7 | 5 | — | 36 |
| Marital Status(Participants) | TargEted MAnageMent Intervention (TEAM) | Enhanced Treatment as Usual (ETAU) | Phase 1 Stakeholders | Phase 2: TargEted MAnageMent Intervention (TEAM) - Peer Educators | Phase 2: TargEted MAnageMent Intervention (TEAM) - Care Partners | Total |
|---|---|---|---|---|---|---|
| Single | 7 | 8 | 2 | 0 | — | 17 |
| Married | 76 | 56 | 11 | 5 | — | 148 |
| Separated/Divorced/Widowed | 39 | 61 | 2 | 2 | — | 104 |
| Currently employed/working(Participants) | TargEted MAnageMent Intervention (TEAM) | Enhanced Treatment as Usual (ETAU) | Phase 1 Stakeholders | Phase 2: TargEted MAnageMent Intervention (TEAM) - Peer Educators | Phase 2: TargEted MAnageMent Intervention (TEAM) - Care Partners | Total |
|---|---|---|---|---|---|---|
| Count of participants | 82 | 79 | — | — | — | 161 |
| Residency Status(Participants) | TargEted MAnageMent Intervention (TEAM) | Enhanced Treatment as Usual (ETAU) | Phase 1 Stakeholders | Phase 2: TargEted MAnageMent Intervention (TEAM) - Peer Educators | Phase 2: TargEted MAnageMent Intervention (TEAM) - Care Partners | Total |
|---|---|---|---|---|---|---|
| Rural | 25 | 28 | — | — | — | 53 |
| Urban | 49 | 62 | — | — | — | 111 |
| Suburban | 48 | 35 | — | — | — | 83 |
1 further baseline measures are reported on the registry.
Documents are hosted by the registry — open the source record to download them.
Plan to share: Yes — The final dataset will include self-reported demographic and behavioral data from interviews with the subjects' data. The final dataset will be stripped of identifiers prior to release for sharing; we believe that there remains the possibility of deductive disclosure of subjects with unusual characteristics. Thus, we will make the data and associated documentation available to users only under a data-sharing agreement (national and international are required) that provides for: (1) a commitment to using the data only for research purposes and not to identify any individual participant; (2) a commitment to securing the data using appropriate computer technology; and (3) a commitment to destroying or returning the data after analyses are completed. Beyond this all the information generated from the various study data sets will be made available to the global community in open access journals indexed in pub med or via the internet as described in the dissemination plan.
Supporting information: Study protocol
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Case Western Reserve University